Ignite Creation Date:
2024-05-06 @ 8:19 PM
Last Modification Date:
2024-10-26 @ 3:25 PM
Study NCT ID:
NCT06337357
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-12
First Post:
2024-03-13
Brief Title:
Results of Progressive Resistance Training in Older Type 2 Diabetic Patients With Sarcopenia
Sponsor:
National Geriatric Hospital
Organization:
National Geriatric Hospital
Study Overview
Official Title:
Evaluating Resistance Training for Sarcopenia in Older Patients With Type 2 Diabetes Treatment Outcomes
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A randomized controlled clinical trial that will test how progressive resistance training will impact outcomes of sarcopenia in older patients with type 2 diabetes who have been diagnosed as sarcopenia The intervention will be 12 weeks in duration with approximately 24 sessions of resistance exercises Outcome measures will be collected at baseline 4 8 weeks and 12 weeks
Detailed Description:
Sarcopenia prevalent among geriatric populations involves the progressive loss of muscle mass and decline in muscular function This age-related condition is associated with higher susceptibility to falls comorbidities and mortality Resistance training emerges as a non-pharmacological intervention proven to alleviate and potentially delay the progression of sarcopenia However there are still few studies investigating its effects on outcomes in older patients with diabetes mellitus
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None